<DOC>
	<DOCNO>NCT01028443</DOCNO>
	<brief_summary>The use topical Cyclosporine A early episode endothelial graft rejection penetrate keratoplasty continue administration 6 month reduce course episode recurrence rejection .</brief_summary>
	<brief_title>Efficacy Topical Cyclosporine A Treatment Prevention Graft Rejection Corneal Grafts With Previous Rejection Episodes</brief_title>
	<detailed_description />
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Penetrating keratoplasty eye without vascularization History previous intraocular surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2006</verification_date>
</DOC>